Partnering For Vascular Innovation: How Solesis Advances The Next Generation Of Devices

Vascular device innovation is accelerating, driven by the need for smaller delivery systems, deeper anatomical access, and minimally invasive procedures. But with these advancements come complex tradeoffs—between flexibility and strength, profile and impermeability, and clinical performance and scalable manufacturing. This article explores how material selection and integration are central to overcoming these challenges, especially through hybrid approaches that combine biomedical textiles with polymer coatings. It highlights the importance of balancing miniaturization, barrier performance, and assembly efficiency, and how dual-platform strategies can streamline production without compromising function. Insights into emerging technologies like polymer-based composites and biocompatible adhesives underscore the value of integrated expertise. Solesis, through Secant Group and Polyzen, offers a collaborative model that supports device developers from concept to commercialization.

For those navigating the complexities of vascular innovation, gain a clear view into the materials and partnerships shaping the future.